Cited 7 times in
The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 Inhibition.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.